 

   
 

purposes. I rev1ewed the SEARCH SUBJECT INFORMATION AND CONSENT
FORM with the patient an answered any questions the patient had. The patient then signed the
consent form as a free and voluntary act. A copy of this inf e retained at
our institution.

I personally informed thisﬂ: a specimen(s) would be collected to be used for research

  

 

 

 

  

 

 
    

i
(L \ijm Ci itxvl’g

Chief Complaints: a,

 

I 5 a m h" 5 if: » i . .
Symptoms. MR1 mtg/1’? iii/235W Uggg

 

Clinical Findings:

 

Performance Scale (Karnofsky Score):
1: 100 Asymptomatic El 80-90 Symptomatic but Fully Ambulatory El 60 7O Symptomatic, in bed less than 50% of day

W50 Symptomatic, in bed more than 50% of day, but not bed ridden 1:! 20-30 Bed Ridden

 

 

 

 
  

Current

[1 YES NO

Current
:1 YES

TYPE
NO

Current

El YES NO

Relative

H B ‘N ve
H C N ve
AFP EIN ‘ve
Other:

[:1 Positive:
El Positive:
El Positive:

E1 Positive:

El Negative
B/T Cell Markers:

L PAST MEDICAL HISTOR
Disease Disorder

     

Date

    

   

Treatment

Environmental Hazards:

Smoki H
Packs

Alcohol Consum
Drinks

D Use

[IN
El

EN
UN

1:! Negative

 

Duration

Duration

Duration

Result

El Positive:
El Positive:
1:! Positive:
1:] Positive:

1:1 Positive:

  
 

 

Results

 

Ultrasound
X-Ra

CT
Endosco
MRI
Bio

 
   
     
   
 
 

  
  

Clinical

Location of Involved L Nodes Location of Distant Metastasis

Clinical
T Na M a Stage: it,

 

 

Treatment Information]

 

 

Procedure

Pri Tumor
Detailed Location

Extension of Tumor

L Nodes
Location of L Nodes # of L Nodes

Palpable, Non-Dissected Lymph Nodes
Dissected Lymph Nodes

Distant Metastasis
Detailed Location

reatment

 

  

Pathology Form

 

 

Specimen Information!

Frozen Parafﬁn Block Blood/Serum/Plasma Slide

Diseased Normal Diseased Normal Diseased Normal Diseased Normal
«*9

z

1,.

Time to LN2 Time to Formalin Time to LN2

Prima Tumor
Size Extension of Tumor Distance to NAT

in

x cm 2 J/ 0 cm

Nodes
Location # Examined # Metastasized

Distant Metastasis
Detailed Location

Patho ical S ‘
ij Na; M a Stage: 1L
Notes:

 

 

IMicroscopic Descriptionl

 

 

Cell Distribution Structural Pattern
Diffuse
Mosaic Storiform
Necrosis Fibrosis
L Inﬁltration
Vascular Invasion C
Clusterized
Alveolar Formation
Indian File Calciﬁcation

+ - Adenomatous + Sarcomatous + - L
Cell Glandular cell Round Cell La Cell
Cell Cell Stratiﬁcation Fibroblast Small Cell
Keratin Secretion Osteoblast RS Like
Desmosome Vacuole Inﬂam. Cell
Pearl Gland formation Plasma Cell

Cellular Differentiation: Well Moderate Poor i,

Nuclear : II
Aniso Nucleosis

Nucleolar Prominent
Multinucleated Giant Cell
Mitotic
Nuclear Grade:

Marker
ER ' 1:1 Positive

PR 1:1 Positive
Her- neu ‘ 121 Positive

B-Cell Marker ' 1:1 Positive

T-Cell Marker ' 1:1 Positive
Other: 1:1 Positive

Other: ' 12] Positive

 

 

Final Pathology Report!

Histological Diagnosis: ”0/,“ 'J/JiW/Zr” :977M7/9x" (fey/2‘62 air/WI?
: 4 i " . 7M,

/ zit/M15??? ,Qﬂ’f29WMv%Q/:’a/ ) Grade'é—M/‘T

fl {II/

3 V ; 1’ '

Comments:

 

 

Microscopic Appearance:

1. Histﬂgicglpartem:

    

ATED DIAGNOSTIC PATHOLOGY FORM*

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diffusé CELL DISTRIBUTION + If S . STRUCTURAL PATTERN
Mosaic mm
_ X Stonform
Necrosns é? Fibrosis
L mphocytic Inﬁltration it Palisading
Vascular Invasion 4’ Cystic Degeneration
Clustenzed 1y Bleeding
Alveolar Formation ﬂ’ Myxoid cw
Indian File ,1 Psammoma/Calciﬁcation
2. Cellular features: '

Squamous + - Adenomatous + - Sarcomatous + Lymphomatous

uamoid Cell Glandular cell Round Cell Mice"
Spindle Cell Cell Stratiﬁcation Fibroblast Small Cell
Keratin Secretion Osteoblast RS Cell/RS Like
Desmosome lntracyt. Vacuole Lipoblast Inﬂam. Cell .
Pearl Gland formation Myoblast Plasma CC"

 

 

 

 

 

 

 

 

 

 

 

Otherwise Speciﬁed: p 3???? @7/ @3577 Dg W 9% W

2. CellularDiﬂ'eremiarion:

3. Nuclear

 

 

Well

Poor

 

 

 

 

Modegtely

 

 

Aniso Nucleosis

Nucleolar

Nuclear A

M ultinucleated Giant Cell

Mitotic

Histological Diagnosis:

Nuclear Grade

ima We 49me (“ML

  

 

 

 

 

 

 

